• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Pediatrix Medical Group Announces 47th Annual NEO: The Conference for Neonatology

    2/23/26 6:00:00 AM ET
    $MD
    Hospital/Nursing Management
    Health Care
    Get the next $MD alert in real time by email

    Leading Educational Event Brings Together Neonatal-Perinatal Medicine Clinicians Dedicated to Improving Outcomes in Newborn Care

    Pediatrix® Medical Group, Inc. (NYSE:MD), a leading provider of physician services, is proud to host the 47th annual NEO: The Conference for Neonatology, taking place Feb. 25-27 in Las Vegas. NEO brings together top neonatology experts to discuss current issues and new advances in neonatal medicine.

    For over 45 years, Pediatrix has been a trusted leader in neonatology, caring for or providing diagnostics to approximately one-quarter of all newborn babies in the U.S.

    The national rate of preterm birth remains at an all-time high at 10.4%, meaning about 380,000 babies – one in every ten – were born prematurely in 2024. The March of Dimes' 2025 Report Card, released in November, revealed that the nation received a D+ grade for preterm births for the fourth year in a row.

    "These results underscore the ongoing need for innovation in neonatal-perinatal medicine," said Timothy Biela, M.D., a neonatologist at Pediatrix Neonatology of San Antonio and director of the NEO conference. "We take pride in leading research initiatives and offering continuing education not only for our own clinicians but also for all providers involved in this highly specialized field. Our goal is to enhance outcomes for our tiniest, highest-risk patients."

    Conference Overview

    This year's conference welcomes participants from across the globe to engage with leading experts who will share the latest research, innovations and pressing topics in neonatal-perinatal medicine. Attendees will gain insights from distinguished speakers and participate in interactive sessions designed to foster learning and collaboration among clinicians.

    Session Highlights

    • Transforming Outcomes for Mothers and Babies
    • Neonatal Surgery and Nutrition: Bridging Innovation and Outcomes
    • Patent Ductus Arteriosus Management: Medical vs. Surgical
    • Ethical Considerations in Neonatal Care
    • From Oxygen to Artificial Intelligence: The Future of Neonatal Respiratory Care
    • Advancements in Neonatal Nutrition
    • Neonatal Point-of-Care Ultrasound (POCUS) Pre-Conference Workshop

    These sessions are designed to address both clinical excellence and the evolving challenges faced by neonatal-perinatal teams. The Neonatal POCUS Pre-Conference Workshop offers hands-on experience with cutting-edge ultrasound techniques, supporting the advancement of bedside diagnostics and care.

    Legends of Neonatology Hall of Fame

    Pediatrix is honored to announce that Waldemar Carlo, M.D., will be inducted into the Legends of Neonatology Hall of Fame during the conference. Dr. Carlo is celebrated for his pioneering research in neonatal resuscitation, global health initiatives and commitment to improving neonatal outcomes worldwide. His work has influenced clinical protocols and shaped the next generation of neonatal care providers.

    Accreditation

    Participants attending the NEO conference will have the opportunity to earn accredited continuing education credits. The Pediatrix Center for Research, Education, Quality and Safety is accredited by:

    • The Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians, designating this live activity for a maximum of 20.00 AMA PRA Category 1 Credits™.
    • The American Nurses Credentialing Center's Commission on Accreditation as a provider of nursing continuing professional development, designating this live activity for a maximum of 20.00 nursing contact hours.

    About Pediatrix Medical Group

    Pediatrix® Medical Group, Inc. (NYSE:MD) is a leading provider of physician services. Pediatrix-affiliated clinicians are committed to providing coordinated, compassionate and clinically excellent services to women, babies and children across the continuum of care, both in hospital settings and office-based practices. Specialties include obstetrics, maternal-fetal medicine and neonatology complemented by multiple pediatric subspecialties. The group's high-quality, evidence-based care is bolstered by significant investments in research, education, quality-improvement and safety initiatives. The physician-led company was founded in 1979 as a single neonatology practice and today provides its highly specialized and often critical care services through approximately 4,300 affiliated physicians and other clinicians. To learn more about Pediatrix, visit www.pediatrix.com or follow us on Facebook, Instagram, LinkedIn and the Pediatrix blog. Investment information can be found at www.pediatrix.com/investors.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20260223873892/en/

    For media inquiries, please contact:

    [email protected]

    Get the next $MD alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $MD

    DatePrice TargetRatingAnalyst
    12/16/2024Outperform
    Macquarie
    9/26/2024$8.00 → $14.00Hold → Buy
    Jefferies
    6/7/2024$8.00Sell → Hold
    Deutsche Bank
    2/23/2022$32.00 → $31.00Outperform
    Credit Suisse
    12/22/2021$33.00 → $32.00Outperform
    Credit Suisse
    11/4/2021$29.00 → $27.00Market Perform
    SVB Leerink
    9/27/2021$29.00Market Perform
    SVB Leerink
    8/9/2021$30.00 → $32.00Neutral
    Mizuho
    More analyst ratings

    $MD
    SEC Filings

    View All

    SEC Form 10-K filed by Pediatrix Medical Group Inc.

    10-K - Pediatrix Medical Group, Inc. (0000893949) (Filer)

    2/19/26 7:00:55 AM ET
    $MD
    Hospital/Nursing Management
    Health Care

    Pediatrix Medical Group Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Pediatrix Medical Group, Inc. (0000893949) (Filer)

    2/19/26 6:50:25 AM ET
    $MD
    Hospital/Nursing Management
    Health Care

    SEC Form 10-Q filed by Pediatrix Medical Group Inc.

    10-Q - Pediatrix Medical Group, Inc. (0000893949) (Filer)

    11/3/25 7:00:49 AM ET
    $MD
    Hospital/Nursing Management
    Health Care

    $MD
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Pediatrix Medical Group Announces 47th Annual NEO: The Conference for Neonatology

    Leading Educational Event Brings Together Neonatal-Perinatal Medicine Clinicians Dedicated to Improving Outcomes in Newborn Care Pediatrix® Medical Group, Inc. (NYSE:MD), a leading provider of physician services, is proud to host the 47th annual NEO: The Conference for Neonatology, taking place Feb. 25-27 in Las Vegas. NEO brings together top neonatology experts to discuss current issues and new advances in neonatal medicine. For over 45 years, Pediatrix has been a trusted leader in neonatology, caring for or providing diagnostics to approximately one-quarter of all newborn babies in the U.S. The national rate of preterm birth remains at an all-time high at 10.4%, meaning about 380,00

    2/23/26 6:00:00 AM ET
    $MD
    Hospital/Nursing Management
    Health Care

    Pediatrix Medical Group Reports Fourth Quarter Results

    Pediatrix Medical Group, Inc. (NYSE:MD), a leading provider of physician services, today reported earnings of $0.40 per share for the three months ended December 31, 2025. On a non-GAAP basis, Pediatrix reported Adjusted EPS of $0.50. For the 2025 fourth quarter, Pediatrix reported the following results: Net revenue of $494 million; Net income of $34 million; and Adjusted EBITDA of $66 million. "Our fourth quarter operating results were in line with our revised upward expectations and reflected solid same-unit revenue growth, partially offset by an increase in variable practice incentive compensation," said Mark S. Ordan, Chief Executive Officer of Pediatrix Medical Group. "Ou

    2/19/26 6:00:00 AM ET
    $MD
    Hospital/Nursing Management
    Health Care

    Pediatrix Medical Group 2025 Fourth Quarter Conference Call/Webcast Scheduled for Thursday, February 19, 2026

    Pediatrix Medical Group, Inc. (NYSE:MD) will host an investor conference call and webcast on Thursday, February 19, 2026 at 9:00 a.m. ET to discuss results from operations for the quarter ended December 31, 2025. A detailed press release will be issued the morning of February 19, 2026 before the securities markets open. The investor conference call will be webcast and can be accessed at Pediatrix's website, www.pediatrix.com/investors. ABOUT PEDIATRIX MEDICAL GROUP Pediatrix® Medical Group, Inc. (NYSE:MD) is a leading provider of physician services. Pediatrix-affiliated clinicians are committed to providing coordinated, compassionate and clinically excellent services to women, babies

    2/9/26 6:45:00 AM ET
    $MD
    Hospital/Nursing Management
    Health Care

    $MD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP, CFO and Treasurer Rossi Kasandra H covered exercise/tax liability with 3,676 shares, decreasing direct ownership by 5% to 73,300 units (SEC Form 4)

    4 - Pediatrix Medical Group, Inc. (0000893949) (Issuer)

    3/3/26 5:00:10 PM ET
    $MD
    Hospital/Nursing Management
    Health Care

    EVP, GC, Chief Admin Off & Sec Moore Mary Ann E was granted 39,925 shares and covered exercise/tax liability with 26,931 shares, increasing direct ownership by 10% to 149,236 units (SEC Form 4)

    4 - Pediatrix Medical Group, Inc. (0000893949) (Issuer)

    3/3/26 5:00:12 PM ET
    $MD
    Hospital/Nursing Management
    Health Care

    Chief Executive Officer Ordan Mark S sold $515,430 worth of shares (23,000 units at $22.41), decreasing direct ownership by 7% to 302,805 units (SEC Form 4)

    4 - Pediatrix Medical Group, Inc. (0000893949) (Issuer)

    12/17/25 5:00:02 PM ET
    $MD
    Hospital/Nursing Management
    Health Care

    $MD
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Macquarie initiated coverage on Pediatrix Medical Group

    Macquarie initiated coverage of Pediatrix Medical Group with a rating of Outperform

    12/16/24 7:46:05 AM ET
    $MD
    Hospital/Nursing Management
    Health Care

    Pediatrix Medical Group upgraded by Jefferies with a new price target

    Jefferies upgraded Pediatrix Medical Group from Hold to Buy and set a new price target of $14.00 from $8.00 previously

    9/26/24 7:37:57 AM ET
    $MD
    Hospital/Nursing Management
    Health Care

    Pediatrix Medical Group upgraded by Deutsche Bank with a new price target

    Deutsche Bank upgraded Pediatrix Medical Group from Sell to Hold and set a new price target of $8.00

    6/7/24 8:14:20 AM ET
    $MD
    Hospital/Nursing Management
    Health Care

    $MD
    Leadership Updates

    Live Leadership Updates

    View All

    Pediatrix Board Appoints Kurt D. Newman, M.D. as Independent Director

    Pediatrix Medical Group, Inc. (NYSE:MD), a leading provider of physician services, today announced that its board of directors has appointed Kurt D. Newman, M.D., former President and Chief Executive Officer of Children's National Hospital in Washington, D.C. and Professor Emeritus of Surgery and Pediatrics at George Washington University School of Medicine and Health Sciences, as an independent director, effective July 1, 2025. Dr. Newman, a surgeon and nationally recognized leader in pediatric healthcare and a long-term healthcare executive, served as President and Chief Executive Officer of Children's National Hospital for 12 years, after spending over 25 years there as a pediatric sur

    7/1/25 4:05:00 PM ET
    $MD
    Hospital/Nursing Management
    Health Care

    Pediatrix Announces Strategic Initiatives For Enhanced Shareholder Value Creation

    Executive Chair Mark S. Ordan to Return as Chief Executive Officer Company Redoubles Strategic Focus on Physician Practices and Hospital and Health System Relationships Pediatrix Medical Group, Inc. (NYSE:MD) ("Pediatrix" or "the Company"), a leading provider of physician services, today announced a leadership transition to accelerate its progress in executing a transformational strategy designed to create value for shareholders and other stakeholders. To best position Pediatrix to implement the strategy, which is based on recommitting to the highest standards in clinical excellence and strengthening the Company's hospital relationships, the Company's Board of Directors has appointed Ex

    1/13/25 6:00:00 AM ET
    $MD
    Hospital/Nursing Management
    Health Care

    Pediatrix Board Appoints Sylvia Young as Independent Director

    Pediatrix Medical Group, Inc. (NYSE:MD), the nation's leading provider of highly specialized health care for women, children and babies, today announced that its board of directors has appointed Sylvia Young, a recognized leader in healthcare and long-term healthcare executive, as an independent director, effective May 12, 2023. Ms. Young, a veteran of hospital administration since 1985, most recently served as President and CEO of the HCA Continental Division, a multi-state regional healthcare system that is part of Hospital Corporation of America (HCA). Prior to her appointment to the Denver-based Division headquarters, Ms. Young served as President of HCA's Sunrise Health System, inclu

    5/4/23 4:05:00 PM ET
    $MD
    Hospital/Nursing Management
    Health Care

    $MD
    Financials

    Live finance-specific insights

    View All

    Pediatrix Medical Group Reports Fourth Quarter Results

    Pediatrix Medical Group, Inc. (NYSE:MD), a leading provider of physician services, today reported earnings of $0.40 per share for the three months ended December 31, 2025. On a non-GAAP basis, Pediatrix reported Adjusted EPS of $0.50. For the 2025 fourth quarter, Pediatrix reported the following results: Net revenue of $494 million; Net income of $34 million; and Adjusted EBITDA of $66 million. "Our fourth quarter operating results were in line with our revised upward expectations and reflected solid same-unit revenue growth, partially offset by an increase in variable practice incentive compensation," said Mark S. Ordan, Chief Executive Officer of Pediatrix Medical Group. "Ou

    2/19/26 6:00:00 AM ET
    $MD
    Hospital/Nursing Management
    Health Care

    Pediatrix Medical Group 2025 Fourth Quarter Conference Call/Webcast Scheduled for Thursday, February 19, 2026

    Pediatrix Medical Group, Inc. (NYSE:MD) will host an investor conference call and webcast on Thursday, February 19, 2026 at 9:00 a.m. ET to discuss results from operations for the quarter ended December 31, 2025. A detailed press release will be issued the morning of February 19, 2026 before the securities markets open. The investor conference call will be webcast and can be accessed at Pediatrix's website, www.pediatrix.com/investors. ABOUT PEDIATRIX MEDICAL GROUP Pediatrix® Medical Group, Inc. (NYSE:MD) is a leading provider of physician services. Pediatrix-affiliated clinicians are committed to providing coordinated, compassionate and clinically excellent services to women, babies

    2/9/26 6:45:00 AM ET
    $MD
    Hospital/Nursing Management
    Health Care

    Pediatrix Medical Group Reports Third Quarter Results

    Raises Full Year 2025 Adjusted EBITDA Outlook Range Pediatrix Medical Group, Inc. (NYSE:MD), a leading provider of physician services, today reported earnings of $0.84 per share for the three months ended September 30, 2025. On a non-GAAP basis, Pediatrix reported Adjusted EPS of $0.67. For the 2025 third quarter, Pediatrix reported the following results: Net revenue of $493 million; Net income of $72 million; and Adjusted EBITDA of $87 million. "Our operating results for the third quarter exceeded our expectations and were driven by a combination of reimbursement-related factors, including strong collection activity, higher patient acuity and slightly favorable payor mix, a

    11/3/25 6:00:00 AM ET
    $MD
    Hospital/Nursing Management
    Health Care

    $MD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Pediatrix Medical Group Inc.

    SC 13G - Pediatrix Medical Group, Inc. (0000893949) (Subject)

    11/13/24 4:30:24 PM ET
    $MD
    Hospital/Nursing Management
    Health Care

    Amendment: SEC Form SC 13G/A filed by Pediatrix Medical Group Inc.

    SC 13G/A - Pediatrix Medical Group, Inc. (0000893949) (Subject)

    10/31/24 11:54:57 AM ET
    $MD
    Hospital/Nursing Management
    Health Care

    SEC Form SC 13G/A filed by Pediatrix Medical Group Inc. (Amendment)

    SC 13G/A - Pediatrix Medical Group, Inc. (0000893949) (Subject)

    6/10/24 12:43:02 PM ET
    $MD
    Hospital/Nursing Management
    Health Care